The estimated Net Worth of Carmen Chang is at least $401 Milion dollars as of 17 July 2023. Carmen Chang owns over 333,333 units of Bright Health stock worth over $400,105,166 and over the last 6 years Carmen sold BHG stock worth over $1,234,674.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Carmen Chang BHG stock SEC Form 4 insiders trading
Carmen has made over 18 trades of the Bright Health stock since 2019, according to the Form 4 filled with the SEC. Most recently Carmen bought 333,333 units of BHG stock worth $999,999 on 17 July 2023.
The largest trade Carmen's ever made was selling 10,376,936 units of Bright Health stock on 24 May 2022 worth over $726,386. On average, Carmen trades about 1,518,178 units every 49 days since 2019. As of 17 July 2023 Carmen still owns at least 24,471,264 units of Bright Health stock.
You can see the complete history of Carmen Chang stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Carmen Chang's mailing address?
Carmen's mailing address filed with the SEC is 2855 SAND HILL ROAD, , MENLO PARK, CA, 94025.
Insiders trading at Bright Health
Over the last 4 years, insiders at Bright Health have traded over $229,613 worth of Bright Health stock and bought 7,761,026 units worth $110,418,758 . The most active insiders traders include Forest Baskett, Scott D Sandell oraz Anthony A. Jr. Florence. On average, Bright Health executives and independent directors trade stock every 25 days with the average trade being worth of $5,149,400. The most recent stock trade was executed by George Lawrence Iii Mikan on 14 December 2023, trading 52,500 units of BHG stock currently worth $858,375.
What does Bright Health's logo look like?
Complete history of Carmen Chang stock trades at Genocea Biosciences Inc, Regulus Therapeutics Inc, Savara Inc, Mirum Pharmaceuticals Inc, Trevi Therapeutics, Marker Therapeutics, Akouos, Metacrine, Coursera oraz Bright Health
Bright Health executives and stock owners
Bright Health executives and other stock owners filed with the SEC include:
-
George Lawrence Mikan III,
Vice Chairman, CEO & Pres -
Robert John Sheehy,
Co-Founder & Exec. Chairman -
Catherine R. Smith,
Chief Financial & Admin. Officer -
Simeon Schindelman,
Chief Exec. Officer of Bright HealthCare -
Sanjeev Kumar Srivastava,
Chief Exec. Officer of NeueHealth -
Keith J. Nelsen,
Gen. Counsel & Corp. Sec. -
Elizabeth Ross,
Chief Marketing Officer -
Dr. Tomas David Valdivia M.S.,
Co-Founder and Chief Health & Equity Officer -
Peter W. Sonsini,
10% owner -
Mohamad Makhzoumi,
Director -
Jay Matushak,
Chief Financial Officer -
Michael A Carson,
CEO, Bright HealthCare -
Manuel Kadre,
Director -
Robert J Sheehy,
Director -
Naomi L Allen,
Director -
Matthew G Manders,
Director -
Tomas Valdivia,
CHIEF HEALTH & EQUITY OFFICER -
Simeon Schindelman,
CEO, BRIGHT HEALTHCARE -
Scott D Sandell,
10% owner -
Jeffrey Folick,
-
Venture Partners Ix L.P.Bes...,
-
Carmen Chang,
10% owner -
Sanjeev K Srivastava,
CEO, NEUEHEALTH -
Cathy R Smith,
CFO & CAO -
Enterprise Associates 15, L...,
-
Keith J Nelsen,
GC & CORPORATE SECRETARY -
Joshua Makower,
10% owner -
18 Venture Growth Equity, L...,
-
George Lawrence Iii Mikan,
CEO & President -
Forest Baskett,
10% owner -
Ali Behbahani,
10% owner -
Anthony A. Jr. Florence,
10% owner -
Paul Edward Walker,
10% owner -
Andrew M Slavitt,
Director -
Linda R Gooden,
Director -
Adair Newhall,
Director -
Jeffrey R Immelt,
Director -
Edward T Mathers,
10% owner -
Liza Landsman,
10% owner -
Rick Yang,
10% owner -
Stephen Kraus,
Director -
Jeffery Michael Craig,
GC & Corporate Secretary -
Jeffrey J Scherman,
Chief Accounting Officer -
Jeffrey S Cook,
Chief Operating Officer